FDA welcomes the National Audit Office report on Ofsted
The FDA has welcomed the National Audit Office report on Ofsted, which highlights a number of issues which the union has been raising with its meetings with the department. This includes the effect the 40% decrease in budget over the past decade has had on staff numbers while responsibilities have increased as it moves its remit into new sectors.
It also highlights the point that whilst the number of key targets have been missed, the quality of inspections has increased, which is a demonstration of the hard work of HM Inspectors (HMIs).
Jawad Raza, FDA National Officer for Ofsted, said: “We welcome Ofsted’s assurance that it is looking at a number of these issues, however, now is the time for action. Our members are working longer hours than ever to keep the quality of inspections at the level they are at and that is a testament to the commitment and dedication of HMIs, but goodwill can only last for so long. Ofsted also needs to address the recruitment and retention issues, including pay, which will help to attract new inspectors, increase staff numbers and help to reduce the workload of our members.”
The full report is available here.
It also highlights the point that whilst the number of key targets have been missed, the quality of inspections has increased, which is a demonstration of the hard work of HM Inspectors (HMIs).
Jawad Raza, FDA National Officer for Ofsted, said: “We welcome Ofsted’s assurance that it is looking at a number of these issues, however, now is the time for action. Our members are working longer hours than ever to keep the quality of inspections at the level they are at and that is a testament to the commitment and dedication of HMIs, but goodwill can only last for so long. Ofsted also needs to address the recruitment and retention issues, including pay, which will help to attract new inspectors, increase staff numbers and help to reduce the workload of our members.”
The full report is available here.
Related News
-
Penman re-elected
Earlier this month, it was confirmed that Dave Penman had been re-elected as General Secretary of the FDA.
-
FDA and Fabian Society launch new AI report
Report co-authors Sasjkia Otto and Aoife Donaghy, alongside former No.10 Downing Street Innovation Fellow Alexander De Ville, and FDA General Secretary Dave Penman launch new joint FDA/Fabian Society report at FDA HQ in London.
-
Back civil servants to ‘rewire Whitehall’, report urges
Involve civil servants and properly invest in AI to achieve the productivity and savings the government seeks, a new report from the FDA and the Fabian Society argues.
